seizures

rocket ship blast off fire away take off
Biotech

Rapport's seizure drug hits in phase 2, sending stock soaring

Based on the data, Rapport plans to start two phase 3 trials of RAP-219 in the third quarter of 2026.
Nick Paul Taylor Sep 8, 2025 8:25am
White arrow on a road pointing to the rising sun

Praxis' drug reduces seizures but sees 23% discontinuation rate

Aug 4, 2025 10:22am
ceribell

Why now was the time for Ceribell’s upsized IPO

Oct 15, 2024 4:00pm
ceribell

Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO

Oct 7, 2024 11:30am
brain amyloid alzheimers strings detailed web complicated thought

Praxis epilepsy drug reduces seizures in phase 2 trial

Sep 3, 2024 10:21am
An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am